Does This Biopharma Company’s “Pipeline In A Drug” Cancer Therapy Make Its Stock A Buy?
The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.
Stock Buys
After Rocketing Higher, Can These 3 Biotechs Continue To Soar?
A clinical-stage biotech company focused on developing tumor-specific immunotherapies to fight multiple cancer types and which is also developing a COVID-19 vaccine that could aid in the battle against variant strains of the virus.
These 4 Biotech Penny Stocks Are Buys, According to Analysts
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular… Read More »With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?